Analysis of new designer drugs in post-mortem blood using high-resolution mass spectrometry

Journal of Analytical Toxicology

Volumn 39, Issue 3, 2015, Pages 163-171

  Pasin, Daniel ^a   Bidny, Sergei ^b   Fu, Shanlin ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b NSW Forensic and Analytical Science Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4' METHYLMETHCATHINONE; CATHINONE; DESIGNER DRUG; PHENETHYLAMINE DERIVATIVE; PIPERAZINE DERIVATIVE; PSYCHEDELIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BLOOD ANALYSIS; CALIBRATION; CONTROLLED STUDY; DRUG INTOXICATION; ELECTROSPRAY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID LIQUID EXTRACTION; MASS SPECTROMETRY; NONHUMAN; PIG; SUSSCROFA; SUSSCROFA DOMESTICUS; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ADULT; ANIMAL; BLOOD; CAUSE OF DEATH; DRUG STABILITY; ELECTROSPRAY MASS SPECTROMETRY; FORENSIC TOXICOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MORTALITY; PREDICTIVE VALUE; PROCEDURES; REPRODUCIBILITY; STANDARD; STANDARDS; STATISTICAL MODEL; SUBSTANCE ABUSE; SUBSTANCE-RELATED DISORDERS; VALIDATION STUDY;

ADULT; ANIMALS; AUTOPSY; CALIBRATION; CAUSE OF DEATH; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DESIGNER DRUGS; DRUG STABILITY; FORENSIC TOXICOLOGY; HUMANS; LIMIT OF DETECTION; LINEAR MODELS; LIQUID-LIQUID EXTRACTION; MALE; PREDICTIVE VALUE OF TESTS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; SUS SCROFA;

EID: 84941638890     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bku144     Document Type: Article

References (24)

1. Baumann, M.H., Partilla, J.S., Lehner, K.R. (2013) Psychoactive "bath salts": not so soothing. European Journal of Pharmacology, 698, 1-5.
2. Bell, C., George, C., Kicman, A.T., Traynor, A. (2011) Development of a rapid LC-MS/MS method for direct urinalysis of designer drugs. Drug Testing&Analysis, 3, 496-504.
3. Winder, G.S., Stern, N., Hosanagar, A. (2013) Are "Bath Salts" the next generation of stimulant abuse? Journal of Substance Abuse Treatment, 44, 42-45.
4. Cosbey, S.H., Peters, K.L., Quinn, A., Bentley, A. (2013) Mephedrone (methylmethcathinone) in toxicology casework: a Northern Ireland perspective. Journal of Analytical Toxicology, 37, 74-82.
5. Camilleri, A., Johnston, M.R., Brennan, M., Davis, S., Caldicott, D.G.E. (2010) Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, α-phthalimidopropiophenone and N-ethylcathinone. Forensic Science International, 197, 59-66.
6. Van Hout, M.C., Bingham, T. (2014) Responsible vendors, intelligent consumers: Silk Road, the online revolution in drug trading. International Journal of Drug Policy, 25, 183-189.
7. Wieland, D.M., Halter, M.J., Levine, C. (2012) Bath salts: they are not what you think. Journal of Psychosocial Nursing&Mental Health Services, 50, 17-21.
8. Fass, J.A., Fass, A.D., Garcia, A.S. (2012) Synthetic cathinones (bath salts): legal status and patterns of abuse. Annals of Pharmacotherapy, 46, 436-441.
9. NSW Police Force (2013) New Psychoactive Substances, http://www. police.nsw.gov.au/community_issues/drugs/new_psychoactive_sub stances (accessed April 03, 2014).
10. Spiller, H.A., Ryan, M.L., Weston, R.G., Jansen, J. (2011) Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States. Clinical Toxicology, 49, 499-505.
11. Swortwood, M.J., Boland, D.M., DeCaprio, A.P. (2013) Determination of 32 cathinone derivatives and other designer drugs in serum by comprehensive LC-QQQ-MS/MS analysis. Analytical and Bioanalytical Chemistry, 405, 1383-1397.
12. Sørensen, L.K. (2011) Determination of cathinones and related ephedrines in forensic whole-blood samples by liquid-chromatography-electrospray tandem mass spectrometry. Journal of Chromatography B, 879, 727-736.
13. Kriikku, P.,Wilhelm, L., Schwarz, O., Rintatalo, J. (2011) New designer drug of abuse: 3,4-methylenedioxypyrovalerone (MDPV). Findings From Apprehended Drivers in Finland. Forensic Science International, 210, 195-200.
14. Wang, C.C., Hartmann-Fischbach, P., Krueger, T.R., Wells, T.L., Feineman, A.R., Compton, J.C. (2012) Rapid and sensitive analysis of 3,4-methylenedioxypyrovalerone in equine plasma using liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology, 36, 327-333.
15. Strano-Rossi, S., Anzillotti, L., Castrignanò, E., Romolo, F.S., Chiarotti, M. (2012) Ultra high performance liquid chromatography-electrospray ionization-tandem mass spectrometry screening method for direct analysis of designer drugs, "spice" and stimulants in oral fluid. Journal of Chromatography A, 1258, 37-42.
16. Ibáñez, M., Sancho, J.V., Bijlsma, L., van Nuijs, A.L.N., Covaci, A., Hernández, F. (2014) Comprehensive analytical strategies based on high-resolution time-of-flight mass spectrometry to identify new psychoactive substances. TrAC Trends in Analytical Chemistry, 57, 107-117.
17. Meyer, M.R., Maurer, H.H. (2012) Current applications of highresolution mass spectrometry in drug metabolism studies. Analytical and Bioanalytical Chemistry, 403, 1221-1231.
18. Rosano, T.G., Wood, M., Ihenetu, K., Swift, T.A. (2013) Drug screening in medical examiner casework by high-resolution mass spectrometry (UPLC-MSE-TOF). Journal of Analytical Toxicology, 37, 580-593.
19. Peters, F.T., Maurer, H.H. (2002) Bioanalytical method validation and its implications for forensic and clinical toxicology - a review. Accreditation and Quality Assurance, 7, 441-449.
20. Peters, F.T., Drummer, O.H., Musshoff, F. (2007) Validation of new methods. Forensic Science International, 165, 216-224.
21. National Association of Testing Authorities (2013) Guidelines for the validation and verification of quantitative and qualitative test methods. http://www.nata.com.au/nata/phocadownload/publications/ Guidance:information/tech-notes-informationpapers/technical_note_17.pdf (accessed May 30, 2014).
22. Scientific Working Group for Forensic Toxicology (SWGTOX) (2013) Standard Practices for Method Validation in Forensic Toxicology. Journal of Analytical Toxicology, 37, 452-474.
23. Matuszewski, B.K., Constanzer, M.L., Chavez-Eng, C.M. (2003) Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Analytical Chemistry, 75, 3019-3030.
24. Bidny, S., Kelly, G., Gago, K., David, M., Duong, T., Pasin, D. (2013) The application of high-resolution mass spectrometry and ultra performance liquid chromatography in forensic toxicology for the simultaneous screening and quantification of basic, neutral and acidic drugs in blood. Personal communication. The data were presented at the Forensic and Clinical Toxicology Association (FACTA) meeting, Sydney, 02-04 December 2013.